MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,338,353 | -5.4% | 378,926 | +49.6% | 0.01% | 0.0% |
| Q2 2023 | $58,514,379 | -13.1% | 253,309 | -8.8% | 0.01% | -14.3% |
| Q1 2023 | $67,310,488 | -60.8% | 277,844 | -53.0% | 0.01% | -65.0% |
| Q4 2022 | $171,708,127 | +1467.5% | 591,587 | +251.0% | 0.04% | +1900.0% |
| Q3 2022 | $10,954,000 | +6.2% | 168,544 | +17.0% | 0.00% | -33.3% |
| Q2 2022 | $10,315,000 | -25.0% | 144,087 | +2.8% | 0.00% | +50.0% |
| Q1 2022 | $13,752,000 | +5.7% | 140,152 | -8.8% | 0.00% | -33.3% |
| Q4 2021 | $13,016,000 | +24.8% | 153,601 | +17.5% | 0.00% | 0.0% |
| Q3 2021 | $10,427,000 | -52.0% | 130,688 | -41.4% | 0.00% | -50.0% |
| Q2 2021 | $21,712,000 | -32.1% | 222,895 | -18.5% | 0.01% | -14.3% |
| Q1 2021 | $31,980,000 | +552.5% | 273,405 | +520.1% | 0.01% | +600.0% |
| Q4 2020 | $4,901,000 | -76.4% | 44,093 | -74.8% | 0.00% | -80.0% |
| Q3 2020 | $20,789,000 | +84.7% | 175,084 | +76.2% | 0.01% | +66.7% |
| Q2 2020 | $11,254,000 | +84.3% | 99,374 | +8.7% | 0.00% | +50.0% |
| Q1 2020 | $6,105,000 | -0.6% | 91,445 | +35.7% | 0.00% | -33.3% |
| Q4 2019 | $6,142,000 | -29.3% | 67,409 | -33.1% | 0.00% | 0.0% |
| Q3 2019 | $8,692,000 | -51.4% | 100,816 | -40.9% | 0.00% | -62.5% |
| Q2 2019 | $17,894,000 | +11.5% | 170,725 | +33.3% | 0.01% | 0.0% |
| Q1 2019 | $16,042,000 | -18.3% | 128,063 | -26.5% | 0.01% | -27.3% |
| Q4 2018 | $19,637,000 | -2.2% | 174,204 | +85.7% | 0.01% | +22.2% |
| Q3 2018 | $20,088,000 | +95.2% | 93,814 | +155.0% | 0.01% | +50.0% |
| Q2 2018 | $10,289,000 | -53.8% | 36,786 | -80.7% | 0.01% | -50.0% |
| Q1 2018 | $22,267,000 | -36.4% | 190,653 | -50.0% | 0.01% | -42.9% |
| Q4 2017 | $35,002,000 | +10442.8% | 381,327 | +1355.3% | 0.02% | – |
| Q3 2016 | $332,000 | – | 26,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |